Salts of compounds and their crystalline forms, methods of preparation and uses
Triphenylacetate salts and crystalline forms of rifamycins address solubility and stability issues, enhancing their pharmaceutical potential by providing improved stability and solubility profiles.
Patent Information
- Application Number
- JP2025549721
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-02-24
- Filing Date
- 2024-02-23
- Publication Date
- 2026-02-27
AI Technical Summary
Rifamycins and their derivatives face challenges with high relative molecular mass, high lipophilicity, low water solubility, hygroscopicity, and low bioavailability, leading to difficulties in meeting pharmaceutical requirements for drug discoverability and stability, particularly in crystalline forms.
Development of triphenylacetate salts and their stable crystalline forms, characterized by specific X-ray powder diffraction peaks and differential scanning calorimetry profiles, which enhance stability and solubility, as well as methods for their preparation and use.
The triphenylacetate salts and crystalline forms exhibit improved stability and solubility, addressing the limitations of rifamycins and enabling their pharmaceutical application.